These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N, Gibson SB. Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174 [Abstract] [Full Text] [Related]
3. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. Higuchi H, Bronk SF, Takikawa Y, Werneburg N, Takimoto R, El-Deiry W, Gores GJ. J Biol Chem; 2001 Oct 19; 276(42):38610-8. PubMed ID: 11507096 [Abstract] [Full Text] [Related]
4. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH. Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875 [Abstract] [Full Text] [Related]
5. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. Zhang XD, Franco AV, Nguyen T, Gray CP, Hersey P. J Immunol; 2000 Apr 15; 164(8):3961-70. PubMed ID: 10754286 [Abstract] [Full Text] [Related]
6. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279 [Abstract] [Full Text] [Related]
7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
8. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Hum Pathol; 2005 Oct 01; 36(10):1066-73. PubMed ID: 16226105 [Abstract] [Full Text] [Related]
9. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells. Kong F, You H, Zhao J, Liu W, Hu L, Luo W, Hu W, Tang R, Zheng K. Virol J; 2015 Nov 17; 12():192. PubMed ID: 26577955 [Abstract] [Full Text] [Related]
10. Hepatitis B virus X protein modulates the apoptosis of hepatoma cell line induced by TRAIL. Liang X, Sun W, Gao L, Ma C, Han L, Chen Y. Sci China C Life Sci; 2005 Jun 17; 48(3):277-86. PubMed ID: 16092761 [Abstract] [Full Text] [Related]
11. Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kurbanov BM, Geilen CC, Fecker LF, Orfanos CE, Eberle J. J Invest Dermatol; 2005 Nov 17; 125(5):1010-9. PubMed ID: 16297203 [Abstract] [Full Text] [Related]
12. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424 [Abstract] [Full Text] [Related]
13. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Cell Death Differ; 2004 Jul 15; 11 Suppl 1():S86-96. PubMed ID: 15105837 [Abstract] [Full Text] [Related]
14. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer. Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S, Horvat R, Zeillinger R, Zielinski C, Krainer M. Mol Cancer Res; 2005 Jun 15; 3(6):335-43. PubMed ID: 15972852 [Abstract] [Full Text] [Related]
15. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G. J Leukoc Biol; 2003 Aug 15; 74(2):223-32. PubMed ID: 12885939 [Abstract] [Full Text] [Related]
16. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N, Poulaki V, Mitsiades C, Tsokos M. Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151 [Abstract] [Full Text] [Related]
17. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. Kuang AA, Diehl GE, Zhang J, Winoto A. J Biol Chem; 2000 Aug 18; 275(33):25065-8. PubMed ID: 10862756 [Abstract] [Full Text] [Related]
18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
19. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM. Int J Cancer; 2002 Jun 01; 99(4):491-504. PubMed ID: 11992538 [Abstract] [Full Text] [Related]
20. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Kim K, Fisher MJ, Xu SQ, el-Deiry WS. Clin Cancer Res; 2000 Feb 01; 6(2):335-46. PubMed ID: 10690508 [Abstract] [Full Text] [Related] Page: [Next] [New Search]